Longitudinally extensive spinal cord lesion
Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.
View Frank Gaillard's current disclosuresAt the time the article was last revised Rohit Sharma had no financial relationships to ineligible companies to disclose.
View Rohit Sharma's current disclosures- LESCL
- LETM
- Longitudinaly extensive spinal cord lesion (LESCL)
- Longitudinal extensive transverse myelitis
- Longitudinally extensive transverse myelitis (LETM)
Longitudinally extensive spinal cord lesions (LESCL), also known as longitudinally extensive transverse myelitis (LETM), represent extensive involvement of the spinal cord, with abnormal T2 signal traversing at least three vertebral body segments in length.
Pathology
There are many potential causes, including 1-9:
-
primary CNS autoimmune illness
-
systemic autoimmune illness
paraneoplastic myelitis (e.g. anti-CRMP-5, anti-amphiphysin, anti-Hu)
-
other causes of transverse myelitis
idiopathic
post-infectious or infectious (e.g. HTLV-1-associated myelopathy, poliomyelitis, poliomyelitis-like syndrome, tuberculous myelopathy)
-
vascular
-
toxic
ADVERTISEMENT: Supporters see fewer/no ads
Differential diagnosis
multiple sclerosis: confluent short segment lesions mimicking a longitudinally extensive spinal cord lesion
References
- 1. Barnett Y, Sutton IJ, Ghadiri M et-al. Conventional and Advanced Imaging in Neuromyelitis Optica. AJNR Am J Neuroradiol. 2013; . doi:10.3174/ajnr.A3592 - Pubmed citation
- 2. Matsuoka T, Matsushita T, Kawano Y et-al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain. 2007;130 (5): 1206-23. doi:10.1093/brain/awm027 - Pubmed citation
- 3. Trebst C, Raab P, Voss EV et-al. Longitudinal extensive transverse myelitis-it's not all neuromyelitis optica. Nat Rev Neurol. 2011;7 (12): 688-98. doi:10.1038/nrneurol.2011.176 - Pubmed citation
- 4. Shan F, Long Y, Qiu W. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature. (2018) Frontiers in immunology. 9: 2802. doi:10.3389/fimmu.2018.02802 - Pubmed
- 5. Birnbaum J, Lalji A, Piccione E, Izbudak I. Magnetic Resonance Imaging of the Spinal Cord in the Evaluation of 3 Patients with Sensory Neuronopathies: Diagnostic Assessment, Indications of Treatment Response, and Impact of Autoimmunity: A Case Report. Medicine (Baltimore). 2017;96(49):e8483. doi:10.1097/MD.0000000000008483 - Pubmed
- 6. Dixon L, McNamara C, Dhasmana D, Taylor G, Davies N. Imaging Spectrum of HTLV-1–Related Neurologic Disease. Neur Clin Pract. 2023;13(3):e200147. doi:10.1212/cpj.0000000000200147 - Pubmed
- 7. Holroyd K & Berkowitz A. Metabolic and Toxic Myelopathies. CONTINUUM: Lifelong Learning in Neurology. 2024;30(1):199-223. doi:10.1212/con.0000000000001376 - Pubmed
- 8. Md Noh M, Bahari N, Abdul Rashid A. Tuberculous Myelopathy Associated with Longitudinally Extensive Lesion: A Clinicoradiological Review of Reported Cases. J Clin Neurol. 2020;16(3):369-75. doi:10.3988/jcn.2020.16.3.369 - Pubmed
- 9. Passeri M, Matthews E, Kammeyer R, Piquet A. Update in Autoimmune and Paraneoplastic Myelopathies: Newly Described Antigen Targets and Antibody Testing. Front Neurol. 2022;13:972143. doi:10.3389/fneur.2022.972143 - Pubmed
Incoming Links
- Autoimmune glial fibrillary acid protein (GFAP) astrocytopathy
- Acute flaccid myelitis
- Neuromyelitis optica spectrum disorder
- Surfer's myelopathy
- Neurosyphilis
- Spinal dural arteriovenous fistula
- Sjögren syndrome
- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
- Neurosarcoidosis
- HTLV-1-associated myelopathy
- Trident sign (neurosarcoidosis)
- Medical abbreviations and acronyms (L)
- Behçet disease (CNS manifestations)
- Transverse myelitis
- Bagel sign (Behçet disease)
Related articles: White matter disorders
- white matter
- normal myelination
- terminology
-
white matter disorders
-
demyelination
- general articles
- acute disseminated encephalomyelitis (ADEM)
- acute haemorrhagic encephalomyelitis (AHEM)
- anti-MOG associated encephalomyelitis (MOGAD)
- neuromyelitis optica spectrum disorder (NMOSD)
-
multiple sclerosis (MS)
-
McDonald diagnostic criteria for MS (2017 revision)
- previous 2016 MAGNIMS consensus
- signs
- variants
-
McDonald diagnostic criteria for MS (2017 revision)
- radiologically isolated syndrome (RIS)
- clinically isolated syndrome (CIS)
- astrocytopathies
- leukoaxonopathies
- early-onset neuronal degenerative disorders
- giant axonal neuropathy
- hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)
- hypomyelination with congenital cataract
- leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
- hypomyelination with brainstem and spinal cord involvement and leg spasticity
- pol III-related leukodystrophies
- leukovasculopathies
- CADASIL
- CARASIL
- cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL)
- cerebral amyloid angiopathy
- COL4A1 brain small-vessel disease
- Fabry disease
- heterozygous HTRA1-related cerebral small vessel disease
- leukoencephalopathy with calcifications and cysts (Labrun syndrome)
- pontine autosomal dominant microangiopathy with leukoencephalopathy (PADMAL)
- retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)
- microgliopathies
- myelin disorders
- hypomyelination
- demyelination
- myelin vacuolisation
- other
- adult polyglucosan body disease
- adult-onset autosomal dominant leukodystrophy
- cerebrotendinous xanthomathosis
- cystic leukoencephalopathy without megalencephaly
- L-2-hydroxyglutaric aciduria
-
lysosomal storage diseases
- free sialic acid storage disorders (e.g. Salla disease)
- Niemann-Pick disease
- peroxisomal disorders
- Sjögren-Larsson syndrome
-
demyelination